Skip to content
PDRN Care

PDRN for Stretch Marks: Regenerating Damaged Skin Tissue

Stretch marks (striae distensae) are a form of dermal scarring that affects up to 90% of women during pregnancy and a significant proportion of adolescents during growth spurts, bodybuilders, and individuals who experience rapid weight changes. They occur when the skin is stretched beyond its elastic capacity, causing rupture of collagen and elastin fibers in the dermis. Fresh stretch marks (striae rubrae) appear red or purple due to inflammation and dilated blood vessels, while mature stretch marks (striae albae) become white or silvery as the tissue loses vascularity and becomes atrophic.

How PDRN Targets Stretch Marks

PDRN addresses stretch marks through tissue-level regeneration targeting the damaged dermis. In stretch mark tissue, fibroblasts are sparse and metabolically inactive, surrounded by disorganized collagen and absent elastin fibers. PDRN reactivates these dormant fibroblasts through adenosine A2A receptor signaling, stimulating them to resume production of type I and type III collagen and elastin — the structural proteins destroyed during stretch mark formation. The nucleotide fragments in PDRN enter cells through the salvage pathway, providing DNA building blocks that support increased cellular activity and proliferation within the scar tissue. PDRN's pro-angiogenic effects are particularly important for stretch marks: mature striae are poorly vascularized, which limits nutrient delivery and metabolic waste removal necessary for active tissue repair. By promoting new blood vessel formation, PDRN creates a vascular network that supports sustained regenerative activity. Additionally, PDRN stimulates glycosaminoglycan synthesis, improving hydration and volume within the atrophic tissue, which helps reduce the sunken, textural appearance of stretch marks.

Recommended Products (4)

Conventional treatments for stretch marks — including topical retinoids, chemical peels, microneedling, fractional laser, and radiofrequency — have variable and often disappointing results, particularly for mature white stretch marks. The fundamental challenge is that stretch marks represent a true loss of organized dermal structure that is difficult to rebuild once established.

PDRN (polydeoxyribonucleotide) offers a novel biological approach to stretch mark treatment by directly stimulating the regenerative processes needed to rebuild damaged dermis. Through adenosine A2A receptor activation, PDRN promotes fibroblast proliferation within the atrophic stretch mark tissue, stimulating production of new collagen, elastin, and glycosaminoglycans. This is fundamentally different from treatments that rely on controlled injury (like laser or microneedling alone) — PDRN provides the cellular signals and nucleotide building blocks that enable genuine tissue regeneration.

For striae rubrae (red/fresh stretch marks), PDRN's anti-inflammatory action helps calm the active inflammatory phase while simultaneously beginning the repair process, potentially preventing the progression to more resistant striae albae. For mature white stretch marks, PDRN's ability to promote angiogenesis is critical — it helps re-establish blood supply to avascular scar tissue, creating the conditions necessary for metabolically active repair. Clinical results suggest that PDRN is most effective when combined with microneedling or fractional laser, where it accelerates healing and enhances the quality of new tissue formation.

Frequently Asked Questions

Does PDRN work better on new or old stretch marks?
PDRN shows better results on newer, red/purple stretch marks (striae rubrae) because these still have active blood supply, viable fibroblasts, and ongoing biological processes that PDRN can enhance. However, PDRN can also improve older white stretch marks (striae albae) by promoting angiogenesis to re-establish blood flow and reactivating dormant fibroblasts. Older stretch marks typically require more treatment sessions and combination approaches (such as PDRN with microneedling) to achieve visible improvement.
Can PDRN prevent stretch marks during pregnancy?
While no treatment can guarantee prevention of stretch marks, topical PDRN use during pregnancy may help maintain skin elasticity and support the dermis during rapid stretching. PDRN's ability to stimulate collagen and elastin production could help the skin accommodate expansion more effectively. However, pregnant women should consult their obstetrician before starting any new skincare treatment. Topical PDRN is generally considered low-risk, but injectable treatments are typically deferred until after pregnancy and breastfeeding.
How is PDRN applied for stretch mark treatment?
For stretch marks, PDRN is most commonly delivered through microneedling — the micro-channels drive PDRN directly into the affected dermal tissue where it can stimulate fibroblasts. Professional treatments typically involve 4-8 sessions spaced 3-4 weeks apart. Some clinics use intradermal PDRN injections directly into the stretch mark tissue for more targeted delivery. Between professional sessions, daily application of topical PDRN serum over the stretch marks supports ongoing repair, though topical penetration is limited compared to professional delivery methods.
What results can I realistically expect from PDRN for stretch marks?
PDRN can improve the color, texture, and depth of stretch marks, but complete elimination is unlikely with any current treatment. Realistic expectations include fading of redness in newer marks, improved skin texture and reduced indentation, and gradual blending of stretch marks with surrounding skin. Most patients see 30-60% improvement in overall appearance after a full treatment course, with the best results achieved through combination therapy (PDRN + microneedling or fractional laser). Maintenance treatments every 2-3 months help sustain improvements.

Sources

  1. Galeano M, Bitto A, Altavilla D, Minutoli L, Polito F, Calo M, Lo Cascio P, d'Alcontres FS, Squadrito F. “Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse.” Wound Repair and Regeneration 16(2): 208-217 (2008). doi:10.1111/j.1524-475X.2008.00361.x
  2. Colangelo MT, Galli C, Guizzardi S. “Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration.” Current Pharmaceutical Design 26(17): 2049-2056 (2020). doi:10.2174/1381612826666200113091156

Other PDRN Skin Concerns

PDRN for Acne Scars

Acne scars represent one of the most challenging dermatological conditions to treat, affecting an es

PDRN for Anti-Aging

Skin aging is a complex biological process driven by both intrinsic factors (genetics, hormonal chan

PDRN for Dark Circles

Dark circles under the eyes are one of the most common cosmetic complaints, affecting people of all

PDRN for Enlarged Pores

Enlarged pores are one of the most common aesthetic complaints, affecting patients across all ages a

PDRN for Hair Growth

Hair loss affects approximately 50% of men and 25% of women by the age of 50, with androgenetic alop

PDRN for Hyperpigmentation

Hyperpigmentation is one of the most common dermatological concerns worldwide, affecting an estimate

PDRN for Post-Procedure Recovery

Post-procedure recovery is a critical phase that directly impacts the outcome of aesthetic treatment

PDRN for Rosacea

Rosacea is a chronic inflammatory skin condition affecting over 400 million people worldwide, charac

PDRN for Skin Barrier Repair

The skin barrier — also known as the stratum corneum or acid mantle — is your body's first line of d

PDRN for Skin Hydration

Skin hydration goes far deeper than surface moisture — it reflects the health and function of the en

PDRN for Skin Texture

Skin texture refers to the surface quality of the skin — how smooth, even, and refined it appears an

PDRN for Sun Damage

Sun damage (photoaging) is the single largest contributor to premature skin aging, responsible for u

Browse All PDRN Products

Search

Search across products, blog posts, wiki articles, and more.